Xencor, Inc.

NASDAQ:XNCR

Biotechnology

Healthcare
$34.01 -1.03%

-$0.13 today

Market cap
$2.55B
Beta
0.93
P/E (TTM)
-5.5
EPS (TTM)
-$2.29
52W Low $6.92High $18.69

Volume 1.09M

Average 0.80M

Income Statement

Follow revenue through to earnings.

Revenue

$125.58M

FY 2025 · Annual

+13.7% YoY

Operating Income

-$177.50M

FY 2025 · Annual

Net Income

-$91.92M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue275.11M164.58M174.62M110.49M125.58M
Cost of Revenue192.51M199.56M0227.69M10.51M
Gross Profit82.6M(34.98M)174.62M(117.19M)115.06M
Gross Margin30.0%-21.3%100.0%-106.1%91.6%
Research & Development192.51M199.56M253.6M227.69M239.43M
Selling, General & Admin38.84M47.49M53.38M58.89M63.64M
Operating Expenses38.84M47.49M306.98M61.22M292.57M
Depreciation & Amortization7.49M8.8M11.5M12.11M10.51M
EBITDA90.14M(45.7M)(101.96M)(186.17M)(46.98M)
EBITDA Margin32.8%-27.8%-58.4%-168.5%-37.4%
Operating Income43.77M(82.47M)(132.36M)(178.41M)(177.5M)
Operating Margin15.9%-50.1%-75.8%-161.5%-141.4%
Interest Income862K4.82M18.63M31.93M27.52M
Interest Expense13K0036.64M31.93M
Other Income / Expenses38.86M27.97M12.73M(56.52M)87.87M
Income Before Tax82.63M(54.51M)(119.63M)(234.92M)(89.42M)
Pre-Tax Margin30.0%-33.1%-68.5%-212.6%-71.2%
Income Tax Expense0673K13.66M1.62M2.5M
Net Income82.63M(55.18M)(133.13M)(232.62M)(91.92M)
Net Margin30.0%-33.5%-76.2%-210.5%-73.2%
EPS (Basic)1.42(0.93)(2.08)(3.58)(1.24)
EPS (Diluted)1.37(0.93)(2.08)(3.58)(1.24)
Weighted Avg Shares58.38M59.65M60.5M65.04M74.24M
Weighted Avg Shares (Diluted)60.5M59.65M60.5M65.04M74.24M

XNCR Earnings Waterfall · TTM

NASDAQ:XNCR · Revenue to Net Income

Key Ratios

EPS$-2.17
Gross Margin18.8%
Net Margin-737.3%
P/E Ratio-23.7
P/S Ratio76.7

Analysis

$105.0M of revenue converted into -$163.3M of net income for the selected period. Gross margin is 18.8% and net margin is -737.3%, showing how much revenue survives after costs and taxes. EPS is $-2.17, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 5, 2026

How much revenue does XNCR generate?

Xencor, Inc. (XNCR) reported $125.58M of revenue in fiscal 2025.

Is XNCR profitable?

Xencor, Inc. (XNCR) reported -$91.92M of net income, with a net margin of -73.2%.